查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370221

非侵入性產前檢測市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Non-Invasive Prenatal Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

概要

市場概況：

2022年，全球無創產前檢測市場規模達34億美元。展望未來，IMARC Group預計到2028年市場規模將達到85億美元，2023-2028年年複合成長率（CAGR）為17.2%。

非侵入性產前檢測 (NIPT) 是對孕婦的血液樣本進行產前篩檢的一種形式，以檢測胎兒是否有異常。此測試主要用於透過分析母親血液中的DNA 片段來診斷遺傳性疾病，例如唐氏症（或21 三體症）、愛德華茲症候群（或18 三體症）、帕陶氏症（或13 三體）和特納氏症。該程序消除了各種不穩定和侵入性程序的需要，例如絨毛膜絨毛取樣（CVS），並且可以在懷孕九週後進行。

胎兒遺傳性疾病的日益普及是推動市場成長的關鍵因素之一。此外，生命科學和醫療保健產業領域的技術進步也為市場提供了推動力。例如，DNA定序技術、再生醫學的發展和分子研究的突破為在原始階段對抗任何嚴重疾病的機會創造了巨大的可能性。此外，產前檢測接受度的提高，以及大眾健康意識的提高以及對此類檢測的好處和意義的認知的提高，也推動了市場的成長。醫療保健提供者以及準父母正在採用替代方法來診斷其他遺傳性疾病，包括脊柱裂、腭裂和鐮狀細胞性貧血，並在胎兒發育的早期階段進行治療。此外，高齡產婦（35 歲或以上）生育趨勢的轉變也對市場成長有正面影響。高齡產婦可能會導致許多健康併發症，例如高血壓、生育能力下降、流產風險以及胎兒染色體異常風險增加。

本報告回答的關鍵問題

  • 2022年全球非侵入性產前檢測市場規模有多大？
  • 2023-2028年全球非侵入性產前檢測市場的預期成長率為何？
  • 推動全球無創產前檢測市場的關鍵因素是什麼？
  • COVID-19對全球無創產前檢測市場有何影響
  • 根據產品類型，全球非侵入性產前檢測市場的詳細情形如何？
  • 根據檢測類型，全球無創產前檢測市場的詳細情形如何？
  • 基於該技術的全球無創產前檢測市場格局如何？
  • 基於方法的全球無創產前檢測市場區隔如何？
  • 基於應用的全球無創產前檢測市場區隔如何？
  • 基於最終用戶的全球無創產前檢測市場的詳細情形如何？
  • 全球無創產前檢測市場的重點區域有哪些？
  • 全球無創產前檢測市場的主要企業/參與者有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球無創產前檢測市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：依產品類型分類的市場區隔

  • 耗材
    • 市場走向
    • 市場預測
  • 儀器
    • 市場走向
    • 市場預測

第 7 章：按測試類型分類的市場

  • 馬特尼 21
    • 市場走向
    • 市場預測
  • 和諧
    • 市場走向
    • 市場預測
  • 帕納羅瑪
    • 市場走向
    • 市場預測
  • 驗證
    • 市場走向
    • 市場預測
  • 漂亮
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：依科技分類的市場

  • NGS
    • 市場走向
    • 市場預測
  • 全基因組定序
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：依方法分類市場

  • 超音波檢測
    • 市場走向
    • 市場預測
  • 生化篩選試驗
    • 市場走向
    • 市場預測
  • 母體血漿檢測中的遊離 DNA
    • 市場走向
    • 市場預測
  • 母體血液檢測中的胎兒細胞
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：按應用分類的市場細分

  • 三體性
    • 市場走向
    • 市場預測
  • 微缺失症候群
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 11 章：最終用戶的市場區隔

  • 醫院
    • 市場走向
    • 市場預測
  • 診斷實驗室
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 12 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 13 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 14 章：價值鏈分析

第 15 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies, Inc.
    • Berry Genetics Inc.
    • BGI Genomics Co. Ltd.
    • Eurofins Scientific Services Limited
    • F. Hoffmann-La Roche Ltd
    • GE Healthcare
    • Igenomix
    • Illumina Inc.
    • Laboratory Corporation
    • Natera Inc.
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
    • Yourgene Health plc
Product Code: SR112023A2086

Abstract

Market Overview:

The global non-invasive prenatal testing market size reached US$ 3.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.5 Billion by 2028, exhibiting a growth rate (CAGR) of 17.2% during 2023-2028.

Non-invasive prenatal testing (NIPT) is a form of prenatal screening conducted on a pregnant woman's blood sample to detect the presence of fetal abnormalities. The test is primarily used to diagnose genetic disorders such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13) and Turner syndrome, by analyzing DNA fragments in the mother's blood. The procedure eliminates the need for various precarious and invasive procedures, such as chorionic villus sampling (CVS) and can be performed after nine weeks of pregnancy.

The growing prevalence of genetic disorders of the fetus is one of the key factors driving the market growth. Furthermore, technological advancements in the field of life sciences and healthcare industry is also providing a boost to the market. For instance, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have created immense possibilities to combat the chances of any serious disease at the primitive stage itself. Additionally, the increasing acceptance rate for prenatal testing, along with rising health consciousness and awareness regarding the benefits and significance of such testing among the masses, is also driving the market growth. Healthcare providers, as well as expecting parents, are adopting alternatives to diagnose other genetic disorders, including spina bifida, cleft palate, and sickle cell anemia, and treat them in the early stages of fetal development. Moreover, the shifting trend toward childbearing at high maternal age (35 years or older) is also positively impacting the market growth. Advancing maternal age can lead to numerous health complications, such as high blood pressure, reduced fertility, risk of miscarriage and increased risk of chromosomal anomalies in the fetus.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global non-invasive prenatal testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, test type, technology, method, application and end-user.

Breakup by Product Type:

Consumables

Instruments

Breakup by Test Type:

Materni 21

Harmony

Panaroma

Verifi

NIFTY

Others

Breakup by Technology:

NGS

WGS

Others

Breakup by Method:

Ultrasound Detection

Biochemical Screening Tests

Cell-Free DNA in Maternal Plasma Tests

Fetal Cells in Maternal Blood Tests

Others

Breakup by Application:

Trisomy

Microdeletion Syndrome

Others

Breakup by End-User:

Hospitals

Diagnostic Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the top non invasive prenatal testing companies key players being Agilent Technologies, Inc., Berry Genetics, Inc., BGI Genomics Co., Ltd., Eurofins Scientific Services Limited, F. Hoffmann-La Roche Ltd, GE Healthcare, Igenomix, Illumina Inc., Laboratory Corporation, Natera Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., and Yourgene Health plc.

Key Questions Answered in This Report

  • 1. What was the size of the global non-invasive prenatal testing market in 2022?
  • 2. What is the expected growth rate of the global non-invasive prenatal testing market during 2023-2028?
  • 3. What are the key factors driving the global non-invasive prenatal testing market?
  • 4. What has been the impact of COVID-19 on the global non-invasive prenatal testing market
  • 5. What is the breakup of the global non-invasive prenatal testing market based on the product type?
  • 6. What is the breakup of the global non-invasive prenatal testing market based on the test type?
  • 7. What is the breakup of the global non-invasive prenatal testing market based on the technology?
  • 8. What is the breakup of the global non-invasive prenatal testing market based on the method?
  • 9. What is the breakup of the global non-invasive prenatal testing market based on the application?
  • 10. What is the breakup of the global non-invasive prenatal testing market based on the end-user?
  • 11. What are the key regions in the global non-invasive prenatal testing market?
  • 12. Who are the key companies/players in the global non-invasive prenatal testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Non-Invasive Prenatal Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Materni 21
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Harmony
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Panaroma
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Verifi
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 NIFTY
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 NGS
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 WGS
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Method

  • 9.1 Ultrasound Detection
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biochemical Screening Tests
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cell-Free DNA in Maternal Plasma Tests
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Fetal Cells in Maternal Blood Tests
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Trisomy
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Microdeletion Syndrome
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by End-User

  • 11.1 Hospitals
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Diagnostic Laboratories
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies, Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Berry Genetics Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 BGI Genomics Co. Ltd.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Eurofins Scientific Services Limited
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 F. Hoffmann-La Roche Ltd
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 SWOT Analysis
    • 16.3.6 GE Healthcare
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Igenomix
      • 16.3.7.1 Company. Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 Illumina Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Laboratory Corporation
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Natera Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Perkinelmer Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Thermo Fisher Scientific Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Yourgene Health plc
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials

List of Figures

  • Figure 1: Global: Non-Invasive Prenatal Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Non-Invasive Prenatal Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Non-Invasive Prenatal Testing Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Non-Invasive Prenatal Testing Market: Breakup by Test Type (in %), 2022
  • Figure 5: Global: Non-Invasive Prenatal Testing Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Non-Invasive Prenatal Testing Market: Breakup by Method (in %), 2022
  • Figure 7: Global: Non-Invasive Prenatal Testing Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Non-Invasive Prenatal Testing Market: Breakup by End-User (in %), 2022
  • Figure 9: Global: Non-Invasive Prenatal Testing Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 11: Global: Non-Invasive Prenatal Testing (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Non-Invasive Prenatal Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Non-Invasive Prenatal Testing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Non-Invasive Prenatal Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Non-Invasive Prenatal Testing (Materni 21) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Non-Invasive Prenatal Testing (Materni 21) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Non-Invasive Prenatal Testing (Harmony) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Non-Invasive Prenatal Testing (Harmony) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Non-Invasive Prenatal Testing (Panaroma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Non-Invasive Prenatal Testing (Panaroma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Non-Invasive Prenatal Testing (Verifi) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Non-Invasive Prenatal Testing (Verifi) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Non-Invasive Prenatal Testing (NIFTY) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Non-Invasive Prenatal Testing (NIFTY) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Non-Invasive Prenatal Testing (NGS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Non-Invasive Prenatal Testing (NGS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Non-Invasive Prenatal Testing (WGS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Non-Invasive Prenatal Testing (WGS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Non-Invasive Prenatal Testing (Trisomy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Non-Invasive Prenatal Testing (Trisomy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Non-Invasive Prenatal Testing (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Non-Invasive Prenatal Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: North America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: North America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: United States: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: United States: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Canada: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Canada: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Asia Pacific: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Asia Pacific: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: China: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: China: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Japan: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Japan: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: India: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: India: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: South Korea: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: South Korea: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Australia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Australia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Indonesia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Indonesia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Europe: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Europe: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Germany: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Germany: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: France: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: France: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: United Kingdom: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: United Kingdom: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Italy: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Italy: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Spain: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Spain: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Russia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Russia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Latin America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Latin America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Brazil: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Brazil: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Mexico: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Mexico: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 99: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 100: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 101: Middle East and Africa: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 102: Middle East and Africa: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 103: Global: Non-Invasive Prenatal Testing Industry: SWOT Analysis
  • Figure 104: Global: Non-Invasive Prenatal Testing Industry: Value Chain Analysis
  • Figure 105: Global: Non-Invasive Prenatal Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Non-Invasive Prenatal Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 4: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 5: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Method (in Million US$), 2023-2028
  • Table 6: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 7: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 8: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 9: Global: Non-Invasive Prenatal Testing Market Structure
  • Table 10: Global: Non-Invasive Prenatal Testing Market: Key Players